ScoreWhy is American Vietnamese Biotech, Inc. ?
1
With a fall in PBT of -256.88%, the company declared Very Negative results in Mar 25
- The company has declared negative results in Jan 70 after 2 consecutive negative quarters
- NET SALES(Q) At VND 63,555.05 MM has Fallen at -17.95%
- PRE-TAX PROFIT(Q) At VND -2,719.45 MM has Fallen at -238.56%
- NET PROFIT(Q) At VND -3,070.83 MM has Fallen at -365.29%
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -10.00%, its profits have fallen by -113.8%
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -10.00% returns in the last 1 year, the stock has also underperformed Vietnam VN Ho Chi Minh Index in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Medical Specialties)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is American Vietnamese Biotech, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
American Vietnamese Biotech, Inc.
-10.0%
-0.90
59.81%
Vietnam VN Ho Chi Minh Index
43.89%
2.03
21.59%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-3.99%
EBIT Growth (5y)
-182.66%
EBIT to Interest (avg)
2.61
Debt to EBITDA (avg)
1.50
Net Debt to Equity (avg)
0.09
Sales to Capital Employed (avg)
0.15
Tax Ratio
58.86%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.68%
ROE (avg)
4.40%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
9.58
EV to EBITDA
3.44
EV to Capital Employed
0.08
EV to Sales
0.45
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.86%
ROE (Latest)
-0.11%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for American Vietnamese Biotech, Inc.
Operating Cash Flow
Highest at VND 926,218.5 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (VND MM)
Inventory Turnover Ratio
Highest at 1.72%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 1.6%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Depreciation
Highest at VND 8,582.56 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (VND MM)
Here's what is not working for American Vietnamese Biotech, Inc.
Net Sales
At VND 63,555.05 MM has Fallen at -17.95%
over average net sales of the previous four periods of VND 77,456.79 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (VND MM)
Pre-Tax Profit
At VND -2,719.45 MM has Fallen at -238.56%
over average net sales of the previous four periods of VND 1,962.7 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (VND MM)
Net Profit
At VND -3,070.83 MM has Fallen at -365.29%
over average net sales of the previous four periods of VND 1,157.55 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (VND MM)
Interest
At VND 10,460.37 MM has Grown at 26.95%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (VND MM)
Debt-Equity Ratio
Highest at 9.01 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Cash and Eqv
Lowest at VND 21,437.02 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Raw Material Cost
Grown by 33.27% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
